| Symbol |
Name |
|
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACO2
|
aconitase 2, mitochondrial
|
|
ACVR1B
|
activin A receptor, type IB
|
|
ACVR1C
|
activin A receptor, type IC
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AHSP
|
alpha hemoglobin stabilizing protein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIMP1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
APMAP
|
adipocyte plasma membrane associated protein
|
|
APOB
|
apolipoprotein B
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ART4
|
ADP-ribosyltransferase 4 (Dombrock blood group)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP6V1E1
|
ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1
|
|
B2M
|
beta-2-microglobulin
|
|
B4GALT6
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAGE
|
B melanoma antigen
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C1R
|
complement component 1, r subcomponent
|
|
C1S
|
complement component 1, s subcomponent
|
|
C4ORF26
|
chromosome 4 open reading frame 26
|
|
C9
|
complement component 9
|
|
CA9
|
carbonic anhydrase IX
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCK
|
cholecystokinin
|
|
CCNC
|
cyclin C
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CDC7
|
cell division cycle 7
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CECR2
|
cat eye syndrome chromosome region, candidate 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHMP6
|
charged multivesicular body protein 6
|
|
CKM
|
creatine kinase, muscle
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
|
CLEC4A
|
C-type lectin domain family 4, member A
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CMTM1
|
CKLF-like MARVEL transmembrane domain containing 1
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRELD2
|
cysteine-rich with EGF-like domains 2
|
|
CRYAA
|
crystallin, alpha A
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSNK1G1
|
casein kinase 1, gamma 1
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CSTF2T
|
cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTSD
|
cathepsin D
|
|
CTSL
|
cathepsin L
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
DAP
|
death-associated protein
|
|
DAZAP1
|
DAZ associated protein 1
|
|
DDX11
|
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DEFB103A
|
defensin, beta 103A
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEK
|
DEK proto-oncogene
|
|
DFNA53
|
deafness, autosomal dominant 53
|
|
DGKE
|
diacylglycerol kinase, epsilon 64kDa
|
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4
|
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional)
|
|
DSG1
|
desmoglein 1
|
|
DSG3
|
desmoglein 3
|
|
DYX1
|
dyslexia susceptibility 1
|
|
EDA
|
ectodysplasin A
|
|
EGFR
|
epidermal growth factor receptor
|
|
EN2
|
engrailed homeobox 2
|
|
EPHA3
|
EPH receptor A3
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
EVI5
|
ecotropic viral integration site 5
|
|
EYS
|
eyes shut homolog (Drosophila)
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAM69A
|
family with sequence similarity 69, member A
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAT4
|
FAT atypical cadherin 4
|
|
FBN1
|
fibrillin 1
|
|
FECD3
|
Corneal dystrophy, Fuchs endothelial, 3
|
|
FGFRL1
|
fibroblast growth factor receptor-like 1
|
|
FKBP10
|
FK506 binding protein 10, 65 kDa
|
|
FN1
|
fibronectin 1
|
|
FTO
|
fat mass and obesity associated
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GANC
|
glucosidase, alpha; neutral C
|
|
GATSL3
|
GATS protein-like 3
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GFPT1
|
glutamine--fructose-6-phosphate transaminase 1
|
|
GGCX
|
gamma-glutamyl carboxylase
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GRK1
|
G protein-coupled receptor kinase 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HARS
|
histidyl-tRNA synthetase
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HK1
|
hexokinase 1
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HMGB1
|
high mobility group box 1
|
|
HMGXB4
|
HMG box domain containing 4
|
|
HOPX
|
HOP homeobox
|
|
HPSE2
|
heparanase 2 (inactive)
|
|
HSD3B7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
|
|
HTT
|
huntingtin
|
|
IDDM8
|
insulin-dependent diabetes mellitus 8
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IHH
|
indian hedgehog
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6R
|
interleukin 6 receptor
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
JAG1
|
jagged 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT10
|
keratin 10, type I
|
|
LAMC2
|
laminin, gamma 2
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LPIN2
|
lipin 2
|
|
MAP3K13
|
mitogen-activated protein kinase kinase kinase 13
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MED25
|
mediator complex subunit 25
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MGAM
|
maltase-glucoamylase
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR26B
|
microRNA 26b
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MPO
|
myeloperoxidase
|
|
MRPL46
|
mitochondrial ribosomal protein L46
|
|
MST1
|
macrophage stimulating 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC17
|
mucin 17, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO1A
|
myosin IA
|
|
MYO1E
|
myosin IE
|
|
NAGA
|
N-acetylgalactosaminidase, alpha-
|
|
NAT9
|
N-acetyltransferase 9 (GCN5-related, putative)
|
|
NDNL2
|
necdin-like 2
|
|
NDUFAF4
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 4
|
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli)
|
|
NEK1
|
NIMA-related kinase 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NIFK
|
nucleolar protein interacting with the FHA domain of MKI67
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUAK2
|
NUAK family, SNF1-like kinase, 2
|
|
NUP98
|
nucleoporin 98kDa
|
|
ORAOV1
|
oral cancer overexpressed 1
|
|
OTX1
|
orthodenticle homeobox 1
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PACRG
|
PARK2 co-regulated
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE6C
|
phosphodiesterase 6C, cGMP-specific, cone, alpha prime
|
|
PDE7B
|
phosphodiesterase 7B
|
|
PF4
|
platelet factor 4
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLXNA2
|
plexin A2
|
|
PLXNB1
|
plexin B1
|
|
PODXL
|
podocalyxin-like
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLQ
|
polymerase (DNA directed), theta
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PVALB
|
parvalbumin
|
|
RAB18
|
RAB18, member RAS oncogene family
|
|
RAB27B
|
RAB27B, member RAS oncogene family
|
|
RAB3C
|
RAB3C, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
|
RALBP1
|
ralA binding protein 1
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RB1
|
retinoblastoma 1
|
|
RET
|
ret proto-oncogene
|
|
RGS12
|
regulator of G-protein signaling 12
|
|
RGSL1
|
regulator of G-protein signaling like 1
|
|
RHD
|
Rh blood group, D antigen
|
|
ROGDI
|
rogdi homolog (Drosophila)
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPL5
|
ribosomal protein L5
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RTN3
|
reticulon 3
|
|
RTN4
|
reticulon 4
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
S100A11
|
S100 calcium binding protein A11
|
|
SATB1
|
SATB homeobox 1
|
|
SCHIP1
|
schwannomin interacting protein 1
|
|
SEMA4F
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFTPB
|
surfactant protein B
|
|
SIRT1
|
sirtuin 1
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC24A4
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4
|
|
SLC25A18
|
solute carrier family 25 (glutamate carrier), member 18
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC33A1
|
solute carrier family 33 (acetyl-CoA transporter), member 1
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SMOC1
|
SPARC related modular calcium binding 1
|
|
SMOC2
|
SPARC related modular calcium binding 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SOX7
|
SRY (sex determining region Y)-box 7
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SSC4D
|
scavenger receptor cysteine rich family, 4 domains
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
SUGCT
|
succinyl-CoA:glutarate-CoA transferase
|
|
SYNJ2
|
synaptojanin 2
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF12
|
transcription factor 12
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
|
TF
|
transferrin
|
|
TFRC
|
transferrin receptor
|
|
TMEM67
|
transmembrane protein 67
|
|
TMEM70
|
transmembrane protein 70
|
|
TMIE
|
transmembrane inner ear
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNXB
|
tenascin XB
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPBG
|
trophoblast glycoprotein
|
|
TPO
|
thyroid peroxidase
|
|
TPRN
|
taperin
|
|
TRAK1
|
trafficking protein, kinesin binding 1
|
|
TRAPPC6A
|
trafficking protein particle complex 6A
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS25
|
vacuolar protein sorting 25 homolog (S. cerevisiae)
|
|
VWF
|
von Willebrand factor
|
|
WASF3
|
WAS protein family, member 3
|
|
WDR1
|
WD repeat domain 1
|
|
WDR36
|
WD repeat domain 36
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XPO1
|
exportin 1
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZIC1
|
Zic family member 1
|
|
ZIC4
|
Zic family member 4
|
|
ZNF280D
|
zinc finger protein 280D
|
|
ZNF296
|
zinc finger protein 296
|
